[{"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204193"], "brand_name": ["DOCETAXEL"], "generic_name": ["DOCETAXEL"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc."], "product_ndc": ["43598-258", "43598-259", "43598-389"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DOCETAXEL"], "rxcui": ["1860480", "1860485", "1861411"], "spl_id": ["b06584c8-f4fd-46dd-a1f2-0e3672b24938"], "spl_set_id": ["a630937b-8369-74ad-b68a-f940eb16ff0f"], "package_ndc": ["43598-258-11", "43598-259-40", "43598-389-57"], "is_original_packager": [true], "unii": ["15H5577CQD"]}, "product_type": "Drugs", "event_id": "82323", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1001-2019", "product_description": "Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.", "product_quantity": "5,755 vials", "reason_for_recall": "Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.", "recall_initiation_date": "20190306", "center_classification_date": "20190312", "termination_date": "20220516", "report_date": "20190320", "code_info": "Lot#: H7081, Exp 07/2019"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040422"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0775", "0555-0971", "0555-0972", "0555-0776", "0555-0777", "0555-0973", "0555-0974"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["541363", "541878", "541892", "577957", "577961", "687043", "1009145"], "spl_id": ["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"], "spl_set_id": ["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"], "package_ndc": ["0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02"], "is_original_packager": [true], "unii": ["JJ768O327N", "O1ZPV620O4", "6DPV8NK46S", "G83415V073"], "upc": ["305550972020"]}, "product_type": "Drugs", "event_id": "72988", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0566-2016", "product_description": "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Sellersville, PA  18960, NDC 0555-0972-02, UPC 3 0555-0972-02 0.", "product_quantity": "9,717 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.", "recall_initiation_date": "20151112", "center_classification_date": "20160111", "termination_date": "20161101", "report_date": "20160120", "code_info": "Lot #: 34015516A, Exp 05/16"}, {"status": "Terminated", "city": "Gainesville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80838", "recalling_firm": "Westlab Pharmacy, Inc. dba Westlab Pharmacy", "address_1": "4410 W Newberry Rd Ste A5", "address_2": "N/A", "postal_code": "32607-2290", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0091-2019", "product_description": "Cyclosporine 1% Human Eye Drops, Westlab Pharmacy, Inc., Gainesville, FL 32607 NDC 10002-2776-92", "product_quantity": "7 droptainers", "reason_for_recall": "Lack of Process Controls", "recall_initiation_date": "20180810", "center_classification_date": "20181024", "termination_date": "20200507", "report_date": "20181031", "code_info": "Lot: 07262018@7 Exp. 08/25/2018"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0747-2019", "product_description": "Dr. King's SafeCare Rx Alcoholism Mind & Body, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955302025, NDC 57955-3021-2", "product_quantity": "41 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 021217A Exp. 02/20"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0303-2023", "product_description": "MEROPENEM (a) 1000MG IN NS 250ML, (b) 2GM IN NS 100ML, (c) 500mg IN NS 125ML, antibiotic, Rx Only, use with home pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "91 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 24-31, 2022"}, {"status": "Terminated", "city": "Woodcliff Lake", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88326", "recalling_firm": "Professional Disposables International, Inc", "address_1": "400 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "07677-7604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-0762-2021", "product_description": "PDI Povidone-Iodine Cleansing Scrub Swabstick (1's), 1 Swabstick, Professional Disposable International, Inc., Orangeburg, NY 10962 -1376 Reorder No S48050, NDC 10819-3891-2, UPC  (01)00310819000192.", "product_quantity": "5,477 cases", "reason_for_recall": "SubPotent: Out of Specification", "recall_initiation_date": "20210723", "center_classification_date": "20210820", "termination_date": "20230531", "report_date": "20210901", "code_info": "Lot #'s 11901081, EXP 2023-04-04; 11901340, EXP 2023-04-05; 11901593, EXP 2023-04-06; 11901594, EXP 2023-04-07; 12000784, EXP 2023-04-08; 12000992, EXP 2023-04-09; 12001492, EXP 2023-04-10; 12001699, EXP 2023-04-11; 12100121, EXP 2023-04-12; 12100453, EXP 2023-04-13;"}, {"status": "Completed", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA020563"], "brand_name": ["HUMALOG"], "generic_name": ["INSULIN LISPRO"], "manufacturer_name": ["Eli Lilly and Company"], "product_ndc": ["0002-7510", "0002-7533", "0002-8799", "0002-7516", "0002-7714", "0002-8213", "0002-0800", "0002-7712", "0002-8208"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["INSULIN LISPRO"], "rxcui": ["242120", "865098", "1652239", "1652242", "1652639", "1652640", "1652644", "1652646", "1926331", "1926332", "2621571", "2621572"], "spl_id": ["3d52c48f-89cd-4d3d-8db6-1789e76a1c79"], "spl_set_id": ["c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f"], "package_ndc": ["0002-7510-01", "0002-7510-17", "0002-7510-99", "0002-7533-01", "0002-8799-01", "0002-8799-59", "0002-8799-61", "0002-7516-01", "0002-7516-59", "0002-7516-99", "0002-7714-01", "0002-7714-59", "0002-7714-61", "0002-8213-01", "0002-8213-05", "0002-0800-01", "0002-7712-01", "0002-7712-27", "0002-7712-61", "0002-8208-01", "0002-8208-27"], "is_original_packager": [true], "nui": ["N0000004931", "N0000175453"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["GFX7QIS1II", "059QF0KO0R"]}, "product_type": "Drugs", "event_id": "94214", "recalling_firm": "Eli Lilly & Company", "address_1": "893 S Delaware St", "address_2": "", "postal_code": "46225-1782", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide USA", "recall_number": "D-0445-2024", "product_description": "Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY with Insulins listed on carton, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285.  NDC: 0002-0800-01", "product_quantity": "700 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240312", "center_classification_date": "20240417", "report_date": "20240424", "code_info": "Batch number: D608951C, exp 4/10/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82615", "recalling_firm": "Customceutical Compounding", "address_1": "4611 E Shea Blvd Bldg 3 Ste 180", "address_2": "N/A", "postal_code": "85028-4258", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1256-2019", "product_description": "HCG (CHORIONIC GONADOTROPIN 1000 IU/ML PEP  25 mg/mL) inj 5 mL multidose vial compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272", "product_quantity": "12 vials", "reason_for_recall": "Lack of assurance of sterility for injectables and solutions intended to be sterile.", "recall_initiation_date": "20190408", "center_classification_date": "20190430", "termination_date": "20230519", "report_date": "20190508", "code_info": "Lot #: 03132019@23, Exp 5/12/19"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0294-2018", "product_description": "Medline Suture Removal Kit, Sterile, Single Use Only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "1,250 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDS1010; Lots 15EB9408", "more_code_info": ""}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67995", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA", "recall_number": "D-1343-2014", "product_description": "phosLo (calcium acetate) GelCaps, 667 mg, 200-count bottle, Rx only, Manufactured for Fresenius Medical Care North America, Waltham, MA 02451, NDC 0781-2081-02", "product_quantity": "14,496 bottles", "reason_for_recall": "Cross Contamination with Other Products: Potential for contaminant on the cotton packaging inside the bottle.  Chemical analysis of the contaminant found on the cotton was identified as a formulation of 4% Trimipramine methanesulfonate - a tricyclic antidepressant..", "recall_initiation_date": "20140414", "center_classification_date": "20140521", "termination_date": "20150813", "report_date": "20140528", "code_info": "Lot # 13064, 13065, 13066; Exp. 08/18"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0383-2016", "product_description": "MIC w/Methyl B-12 Preserved Injection, 25/50/50/1mg/mL, 50mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "49 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "65 vials", "code_info": "Lot #: 20130130-B, Exp 4/30/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Metoprolol Injection, all strengths and all presentations including Metoprolol 1 mg/mL 5 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-394-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0173-2015", "product_description": "ALPROSTADIL, 10 mcg/mL, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070.", "product_quantity": "5 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140913@10, discard date 10/28/2014"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88154", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0661-2021", "product_description": "Topotecan Injection 4 mg/4mL (1 mg/mL), Single-Dose vial, Teva Pharmaceuticals USA, Inc. North Whales, PA 19454, Carton NDC# 0703-4714-01, Vial NDC# 0703-4714-71", "product_quantity": "10,425 vials", "reason_for_recall": "Presence of Particulate Matter: Complaint received of a glass particle observed inside the vial. The vial was returned to Teva for further analysis where two other particulates were found and identified as one (1) grey silicone particle and one (1) translucent, colorless cotton fiber.", "recall_initiation_date": "20210618", "center_classification_date": "20210715", "termination_date": "20220404", "report_date": "20210714", "code_info": "Lot # 31328962B, exp. date 04/2022", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "33 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  04222015@69, 7/21/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Folic Acid 5 mg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1502-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212294"], "brand_name": ["TAVABOROLE"], "generic_name": ["TAVABOROLE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-102"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TAVABOROLE"], "rxcui": ["1543177"], "spl_id": ["266f7bbc-b540-4681-8144-cbb823f34f0e"], "spl_set_id": ["c13610c8-c57a-4519-b37d-eb4fbdcec398"], "package_ndc": ["72578-102-04"], "is_original_packager": [true], "nui": ["N0000191279", "N0000000150", "M0002832"], "pharm_class_epc": ["Oxaborole Antifungal [EPC]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "pharm_class_cs": ["Boron Compounds [CS]"], "unii": ["K124A4EUQ3"]}, "product_type": "Drugs", "event_id": "97756", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0016-2026", "product_description": "Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04.", "product_quantity": "13080 bottles", "reason_for_recall": "Discoloration - Expansion of RES #97424", "recall_initiation_date": "20251006", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot#: T400819, T400820, Exp 4/30/26; T401969, Exp 9/30/26", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; METOPROLOL TARTRATE Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as    DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: AD68022_1, EXP: 5/28/2014;  METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 57664050652, Pedigree: AD68010_14, EXP: 5/28/2014.", "address_2": "", "product_quantity": "402 Tablets", "code_info": "METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) has the following codes    Pedigree: AD68010_14, EXP: 5/28/2014;  Pedigree: AD68010_17, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "METOPROLOL TARTRATE Tablet, 12.5 mg (1/2 of 25 mg), Rx only, Distributed by: AidaPak Service, LLC,  NDC 57664050652", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-628-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90880", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide and Puerto Rico", "recall_number": "D-1547-2022", "product_description": "Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031,  NDC 61748-015-30", "product_quantity": "18,145 bottles", "reason_for_recall": "Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).", "recall_initiation_date": "20220921", "center_classification_date": "20220928", "report_date": "20221005", "code_info": "Lot#: 3192818, Exp 10/31/2022; 3199700, Exp 03/31/2023; 3203853, Exp 02/29/2024"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0203-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1.5/PGE-1 50 INJ **ST 1**  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "3 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07162021:14 BUD: 11/30/2021; 09142021:63 BUD: 02/08/2022", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium) may be potentially mislabeled as     LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD46265_10, EXP: 5/15/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium) has the following code    Pedigree: AD46257_43, EXP: 5/15/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-474-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2735", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Phenylephrine HCI100mcg/mL in 0.9% sodium Chloride 10ml fill in a 10mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0927-72", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1324-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0203-2021", "product_description": "neostigmine methylsulfate 5 mg/5 mL, (1mg/ml), Rx Only,  5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004075009", "product_quantity": "390 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023044, BUD 1/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1222-2020", "product_description": "Testosterone in Atrevis 75 mg/mL Gel 90 GMS tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45235 Discard by: 9/15/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1203-2019", "product_description": "Prostaglandin Tri-Mix 20:25:1 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "240 bags", "code_info": "Lot # 138-20181505@92, BUD 8/23/2018; 138-20181605@78, BUD 8/24/2018", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "HEPARIN 25,000 Units in 5% Dextrose (Heparin Sodium, USP 25,000 Units, 5% Dextrose Inj., USP 250 mL) Volume: 255 mL. Single dose bag. Avella Specialty Pharmacy, 24416 N 19th Avenue, Pheonix AZ 85085. NDC 42852-729-25", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0934-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ATOMOXETINE HCL, Capsule, 40 mg may be potentially mis-labeled as OLANZAPINE, Tablet, 7.5 mg, NDC 60505311203, Pedigree: AD21790_76, EXP: 5/1/2014;  ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD46265_19, EXP: 5/15/2014;  OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree: AD60272_79, EXP: 5/22/2014;  OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree:  AD73", "address_2": "", "product_quantity": "180 Capsules", "code_info": "ATOMOXETINE HCL, Capsule, 40 mg has the following codes:    Pedigree: AD21790_82, EXP: 5/1/2014;   Pedigree: AD46265_52, EXP: 5/15/2014;  Pedigree: AD60272_89, EXP: 5/22/2014;  Pedigree: AD73525_67, EXP: 5/30/2014;  Pedigree: W003014, EXP: 6/11/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ATOMOXETINE HCL, Capsule, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002322930.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-765-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "32 ml", "code_info": "All lots distributed between November 2014 and May 2015;    04012015@76, 5/31/2015, 04062015@11, 6/5/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Sermorelin 300 mcg/ml + GHRP-2 300 mcg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, DO NOT SHAKE, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1633-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Ranasthalam Mandal, Srikakulam", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA076286"], "brand_name": ["TIZANIDINE"], "generic_name": ["TIZANIDINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-179", "55111-180"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TIZANIDINE HYDROCHLORIDE"], "rxcui": ["313412", "313413"], "spl_id": ["386ec98d-4a47-b025-b050-7e4ebce382c6"], "spl_set_id": ["a42f3479-f2c2-8214-d547-c5cae9bfed1e"], "package_ndc": ["55111-179-30", "55111-179-15", "55111-179-03", "55111-179-10", "55111-180-30", "55111-180-15", "55111-180-03", "55111-180-10"], "is_original_packager": [true], "upc": ["0355111180104", "0355111179108"], "unii": ["B53E3NMY5C"]}, "product_type": "Drugs", "event_id": "92564", "recalling_firm": "Dr Reddy's Laboratories Limited", "address_1": "Fto-Sez Unit 1, Surv. 57-59,60, 62 & 72", "address_2": "Sect. 9-14, 17-20, Devunipalavalasa", "postal_code": "N/A", "voluntary_mandated": "N/A", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0923-2023", "product_description": "Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10", "product_quantity": "17,548 1000-countbottles", "reason_for_recall": "Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.", "recall_initiation_date": "20230621", "center_classification_date": "20230717", "report_date": "20230726", "code_info": "Lot: T2100585, T2100586, T2100587, Exp 12/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77374", "recalling_firm": "Pharmedium Services Llc", "address_1": "150 N Field Dr", "address_2": "N/A", "postal_code": "60045-4847", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0933-2017", "product_description": "Ropivacaine HCl 0.2% 750 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 600 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-279-33", "product_quantity": "10 I.V. pumps", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20170215", "center_classification_date": "20170702", "termination_date": "20200113", "report_date": "20170712", "code_info": "Lot: 170170204s; Exp. 01/01/1900"}, {"status": "Terminated", "city": "Sanford", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67420", "recalling_firm": "Hill Dermaceuticals, Inc.", "address_1": "2650 S Mellonville Ave", "address_2": "N/A", "postal_code": "32773-9311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1181-2014", "product_description": "SETON PHARMACEUTICALS Fluocinolone Acetonide 0.01%  Oil EAR DROPS, 20 ml, Rx only Manufactured by: Hill Dermaceuticals, Inc. For:  Seton Pharmaceuticals NDC 13925-508-20", "product_quantity": "13,591 bottles", "reason_for_recall": "Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.", "recall_initiation_date": "20140131", "center_classification_date": "20140324", "termination_date": "20150203", "report_date": "20140402", "code_info": "13F017B exp. 12/14, 13F020B exp 12/14"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0930-2019", "product_description": "NET Remedies #2 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "800 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: AUS-111517D Exp. 11/19"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1603-2020", "product_description": "Nature-Throid, Thyroid USP [liothyronine (T3) 20.25 mcg and levothyroxine (T4) 85.5 mcg], 2.25 Grain (146.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3309-4; b) 60-count bottles, NDC 64727-3309-5; c) 90-count bottles, NDC 64727-3309-6; d) 100-count bottles, NDC 64727-3309-1; and e) 1,000-count bottles, NDC 64727-3309-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73537", "recalling_firm": "Meditech Laboratories, Inc", "address_1": "3200 Polaris Ave Ste 27", "address_2": "N/A", "postal_code": "89102-8379", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0804-2016", "product_description": "Formula 9 (Papaverine 0.9 mg, Phentolamine 0.1 mg, Atropine 0.01 mg, PGE 20 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV  89102.", "product_quantity": "1320 vials - all formulas", "reason_for_recall": "Lack of Assurance of Sterility: incomplete or missing data regarding production.", "recall_initiation_date": "20160314", "center_classification_date": "20160401", "termination_date": "20160607", "report_date": "20160413", "code_info": "Lot#: 022416-9, Exp 04/09/16.", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg may have potentially been mislabeled as one of the following drugs:  PREGABALIN, Capsule, 200 mg, NDC 00071101768, Pedigree: AD21787_1, EXP: 5/1/2014;  HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 76439030910, Pedigree: AD54501_1, EXP: 5/21/2014;  VARENICLINE, Tablet, 0.5 mg, NDC 00069046856, Pedigree: W003083, EXP: 6/12/2014;  L", "address_2": "", "product_quantity": "2024 Capsules", "code_info": "SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg has the following codes:   Pedigree: AD21859_1, EXP: 10/31/2013;  Pedigree: AD54586_1, EXP: 5/21/2014;  Pedigree: W003030, EXP: 6/12/2014;  Pedigree: W003866, EXP: 6/27/2014;  Pedigree: AD37063_7, EXP: 5/13/2014;  Pedigree: W002917, EXP: 6/10/2014;  Pedigree: AD54586_4, EXP: 5/21/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00414200007.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-911-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Polepally, Jadcherla", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA208302"], "brand_name": ["IMATINIB MESYLATE"], "generic_name": ["IMATINIB MESYLATE"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "product_ndc": ["72485-203"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IMATINIB MESYLATE"], "rxcui": ["403879"], "spl_id": ["2e636646-af84-4711-84b4-9092bb51ca8a"], "spl_set_id": ["7b7cc194-29e4-4484-a364-a1ac7d7d6cf5"], "package_ndc": ["72485-203-30"], "is_original_packager": [true], "upc": ["0372485203307"], "unii": ["8A1O1M485B"]}, "product_type": "Drugs", "event_id": "86749", "recalling_firm": "Shilpa Medicare Limited", "address_1": "S-20 To S-26,  Pharm. Formulation Sez", "address_2": "Tsiic, Green Industrial Park", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0125-2021", "product_description": "Imatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-203-30.", "product_quantity": "4166 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201208", "center_classification_date": "20201209", "termination_date": "20220311", "report_date": "20201216", "code_info": "Lot #s: 7S10032A, 7S10034A, Exp. 02/28/2021"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0067-2020", "product_description": "LIDOcaine HCl 0.75%(7.5 mg/mL)/ EPINRPHrine 0.025% (0.25 mg/mL) (PF) (Sulfite Free) in BSS, 1 mL Fill in a 3 mL Single Dose Syringe, Rx only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678395", "product_quantity": "4105 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "740 syringes", "code_info": "Lot #:2/26/18 2233 24363M, BUD 6/26/2018.", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "MORphine 150 mg (Morphine Sulfate, USP 150mg in 0.9% Sodium Chloride, USP QS 30mL). Volume 30 mL. Single dose syringe. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-243-63", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0954-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89706", "recalling_firm": "Vi-Jon, Inc.", "address_1": "1 Swan Dr", "address_2": "", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one distributor in Texas for further distribution", "recall_number": "D-0644-2022", "product_description": "HEB 50% Isopropyl Alcohol First Aid Antiseptic, packaged in 16 FL OZ 91 PT) 473 mL  brown bottles with brown colored closures. Distributed by HEB San Antonio, TX 78204. UPC 0 41220 25111 7", "product_quantity": "11,580 bottles", "reason_for_recall": "Labeling: Label Mix-Up-The primary label on the front of the bottles have 50% Isopropyl Alcohol affixed to the containers. However, the product inside the bottle is Hydrogen Peroxide, Topical Solution USP with active ingredient Hydrogen Peroxide (stabilized) 3%, 32 FL Ounces.  The back label is correct. Product is packaged in dark bottles.", "recall_initiation_date": "20220302", "center_classification_date": "20220303", "termination_date": "20230815", "report_date": "20220309", "code_info": "Lot: 0546089 Exp. 09/2023", "more_code_info": ""}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave", "reason_for_recall": "Failed Impurities/Degradation Specifications; 9 month stability (manufacturer)", "address_2": "Suite A", "product_quantity": "716 cartons", "code_info": "Lot # 153855, exp 01/2017", "center_classification_date": "20160211", "distribution_pattern": "Nationwide", "state": "OH", "product_description": "Candesartan Cilexetil Tablets, 16 mg, 30 Tablets (5 x 6) blister pack, Rx, Distributed by: American Health Packaging Columbus, Ohio 43217, NDC 68084-877-25(carton), NDC 68084-877-95(individual dose)", "report_date": "20160217", "classification": "Class III", "openfda": {}, "recalling_firm": "Amerisource Health Services", "recall_number": "D-0660-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "73166", "termination_date": "20170111", "more_code_info": "", "recall_initiation_date": "20160126", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-1017-2013", "product_description": "CALCIUM EDTA 300 MG/ML INJECTABLE, all configurations,  FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "01082013@7 and 05062013@29", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0118-2022", "product_description": "HYDROXOCOBALAMIN 5,000MCG/ML INJ 5,000MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08242021:51 BUD: 10/23/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-918-2015", "product_description": "Temozolomide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "975 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0703-2022", "product_description": "Hydrocortisone Butyrate Lotion, 0.1%, 4 fl oz (118 mL) bottle, Rx only, Manufactured for: SOLA Pharmaceuticals, Baton Rouge, LA 70809, NDC 70512-032-04.", "product_quantity": "6874 bottles", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 16896, 16897 Exp. 5/31/2023"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0920-2022", "product_description": "Bimix-3 Papaverine 30 mg/mL Phentolamine 3 mg/mL, Packaged as a) 2.5 mL Multi-Dose Vial, NDC73198-0027-03; b) 10 mL Multi-Dose Vial, NDC 73198-0027-10;  Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835", "product_quantity": "1287 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: J24F20, J24E20 BUD: 10/20/2022, B24G22-22, B24F22-22 BUD: 2/22/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89943", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product distributed in California and Florida.", "recall_number": "D-0771-2022", "product_description": "Econazole Nitrate Cream, 1%, Generic for Spectazole, 30 gm tube, Rx Only, Preferred Pharmaceuticals, Inc., The Physican's Solution, Mfg: Teligent Pharma, Inc., NDC 68788-7406-03", "product_quantity": "41 Tubes", "reason_for_recall": "CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.", "recall_initiation_date": "20220324", "center_classification_date": "20220414", "termination_date": "20231117", "report_date": "20220420", "code_info": "Lot #: A1122P, G1421N, Exp. 1/1/2023"}, {"country": "United States", "city": "Richland", "address_1": "199 Interstate Dr Ste N", "reason_for_recall": "CGMP Deviations; deficiencies at the manufacturer  may result in assay or content uniformity failures", "address_2": "", "product_quantity": "604 bottles", "code_info": "LOT # 29421501, EXP 10/17", "center_classification_date": "20161129", "distribution_pattern": "Nationwide", "state": "MS", "product_description": "AZUPHEN MB URINARY ANTISEPTIC Capsules, Each capsule contains:  Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue 10 mg, Hyoscyamine Sulfate, 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-314-10", "report_date": "20161207", "classification": "Class II", "openfda": {}, "recalling_firm": "Burel Pharmaceuticals Inc", "recall_number": "D-0159-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75566", "termination_date": "20170814", "more_code_info": "", "recall_initiation_date": "20161024", "postal_code": "39218-9433", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Earth City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82326", "recalling_firm": "Legacy Pharmaceutical Packaging LLC", "address_1": "13333 Lakefront Dr", "address_2": "N/A", "postal_code": "63045-1514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Wal-Mart distribution centers in AR, CA, GA, IN and MD", "recall_number": "D-1050-2019", "product_description": "Losartan Potassium Tablets, USP, 100 mg, 30 tablet bottles,  Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for:  Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by:  Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045.  NDC 68645-579-54", "product_quantity": "2,497,856 bottles", "reason_for_recall": "CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected", "recall_initiation_date": "20190301", "center_classification_date": "20190321", "report_date": "20190327", "code_info": "180886, Nov-19; 180887, 180888, 180905, Dec-19;   181123, Sep-2019;   181124, Oct-2019,  181125, Aug-19,  181351, Nov-19,  181352, Dec-19,  181551, Nov-19,  181628, 181629, 181727, 181728, Jun-20;  181890, Mar-20;  181891,  181897, Jun-20;  182114, Mar-20;   182119, 182120, Jun-20"}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83200", "recalling_firm": "Geritrex, LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1526-2019", "product_description": "Gericare Geri-Tussin DM, 16 FL OZ (473 mL), Geri-care Phamaceuticals Corp. 1650 63rd Street  Brooklyn, NY, NDC 57896-660-16", "product_quantity": "6213 bottles", "reason_for_recall": "cGMP Deviations: Products may have microbial contamination.", "recall_initiation_date": "20190531", "center_classification_date": "20190725", "termination_date": "20240202", "report_date": "20190731", "code_info": "Lot #: 70602, Exp 6/19"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71079", "recalling_firm": "Mylan Institutional LLC", "address_1": "4901 Hiawatha Dr", "address_2": "N/A", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1329-2015", "product_description": "Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), packaged in 10 x 5 mL Vials per carton (NDC 0069-0152-02), Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY  10017.", "product_quantity": "8,340 vials", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20150423", "center_classification_date": "20150813", "termination_date": "20160629", "report_date": "20150819", "code_info": "Lot # 7801050, Exp. Date. 05/2015"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA079001"], "brand_name": ["VECURONIUM BROMIDE"], "generic_name": ["VECURONIUM BROMIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-931", "47335-932"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["VECURONIUM BROMIDE"], "rxcui": ["859437"], "spl_id": ["82d6bc45-04a5-409a-9223-da1884b2468f"], "spl_set_id": ["a14da3ee-a731-4282-be9d-407473517470"], "package_ndc": ["47335-931-40", "47335-931-44", "47335-932-40", "47335-932-44"], "is_original_packager": [true], "upc": ["0347335932447"], "unii": ["7E4PHP5N1D"]}, "product_type": "Drugs", "event_id": "81891", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0372-2019", "product_description": "Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilized, 10 x 10 mg vials, Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512  NDC 47335-931-40 [vial] NDC 47335-931-44 [carton]", "product_quantity": "12,534 cartons, 125,340 vials", "reason_for_recall": "Presence of Particulate Matter:  Foreign matter identified as glass detected in Vecuronium Bromide for Injection.", "recall_initiation_date": "20190103", "center_classification_date": "20190114", "termination_date": "20211103", "report_date": "20190116", "code_info": "Lot #: JKS0443A, JKS0444A, JKS0477A, EXP 03/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0081-2016", "product_description": "ESTRADIOL, Pellet, 20 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "9 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12022014@19, t08132014@24, t08042014@40, t07082015@25, t06192015@25, t03192015@5, t02162015@11, t02062015@12."}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "105 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03122015@79, 6/10/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "LIPO-EXTREME Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1686-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New Albany", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "66233", "recalling_firm": "Tween Brands Inc", "address_1": "8323 Walton Pkwy", "address_2": "N/A", "postal_code": "43054-9522", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-348-2014", "product_description": "Believe in Yourself Strawberry Anti bac Justice, Ethyl Alcohol, Net Wt 1 fl oz., Distr by Tween Brands New Albany, OH 43054 Toronto, ON L6T 3R5", "product_quantity": "86,701 bottles", "reason_for_recall": "Labeling: Label Error on Declared Strength; the label states that the product contains 62% ethyl alcohol, but the ethyl alcohol content is 20%.", "recall_initiation_date": "20130621", "center_classification_date": "20131213", "termination_date": "20140616", "report_date": "20131225", "code_info": "Style #190782 & 190864"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63432", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-263-2013", "product_description": "Lactated Ringer's and 5% Dextrose Injection, USP, 1000 mL flexible containers, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7929-09.", "product_quantity": "136,224 flexible containers", "reason_for_recall": "Non-Sterility: One confirmed customer report that product contained spore-like particulates, consistent with mold.", "recall_initiation_date": "20121005", "center_classification_date": "20130417", "termination_date": "20150821", "report_date": "20130424", "code_info": "Lot # :12-160-JT*, Exp 12/01/13; lot number * may be followed by 01 or 90"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0483-2020", "product_description": "FreshKote Lubricant Eye Drops, Product Size: 15 mL, NDC 15821-101-15", "product_quantity": "31070 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 18095, Exp 4/20"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0151-2019", "product_description": "Epi-Shugarcaine Kit Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1409-60", "product_quantity": "70 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "08272018:79 Discard by: 10/1/2018"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-217-2014", "product_description": "Methylprednisolone 40mg PF 2ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "20 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "81796", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0356-2019", "product_description": "Ceftriaxone for Injection USP, 500 mg, packaged in a) one Single Use Vial (NDC 68180-622-01) and b) 10 Single Use Vials per box (NDC 68180-622-10); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland  21202; Manufactured by: Lupin Limited, Mandideep 462 046 INDIA.", "product_quantity": "a) 8,000 vials; b) 32,045 boxes", "reason_for_recall": "Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.", "recall_initiation_date": "20181220", "center_classification_date": "20190114", "termination_date": "20200818", "report_date": "20190116", "code_info": "Lot #: a) C600173, Exp 08/19; C600218, Exp 09/19; b) C600126, C600127, C600137, C600143, Exp 08/19; C600219, Exp 09/19; C700146, Exp 05/20; C700208, C700209, Exp 09/20.", "more_code_info": ""}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "3", "code_info": "C3621 Exp 9/21/13, L3618 Exp 10/31/13, and A0224 Exp 6/30/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Guanabenz 8 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-737-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-136-2014", "product_description": "HCG 340 iu prefilled syringes, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "5315 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA062420"], "brand_name": ["GENTAMICIN SULFATE"], "generic_name": ["GENTAMICIN SULFATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1207"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["GENTAMICIN SULFATE"], "rxcui": ["1870650"], "spl_id": ["90119984-4be7-494f-9ba0-61ec49c15143"], "spl_set_id": ["977180b3-a222-4282-d485-4a3217674305"], "package_ndc": ["0409-1207-13", "0409-1207-03"], "is_original_packager": [true], "unii": ["8X7386QRLV"]}, "product_type": "Drugs", "event_id": "65226", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-686-2013", "product_description": "Gentamicin Sulfate Injection USP 80 mg/2 mL(40 mg/mL as Gentamicin), 2 mL Single-dose Fliptop Vial, (NDC 0409-1207-13), Rx only, Manufactured by Hospira, Inc, Lake Forest, IL 60046 USA.", "product_quantity": "168,300 vals", "reason_for_recall": "Presence of Particulate Matter: visible particles were identified floating in the primary container.", "recall_initiation_date": "20130502", "center_classification_date": "20130708", "termination_date": "20141028", "report_date": "20130717", "code_info": "Lot 07-067-DK Exp. 07/13"}, {"status": "Ongoing", "city": "Thane", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93885", "recalling_firm": "Brassica Pharma Pvt Ltd", "address_1": "Plot No. T-68, T 68 (Pt), T-63, Midc", "address_2": "Tarapur, Boisar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0351-2024", "product_description": "Equate Lubricant Eye Ointment (Mineral Oil 42.5%, White Petrolatum 57.3%), Packaged in 3.5 gram tubes, Distributed by Walmart Inc., Bentonville, AR 72716, NDC 79903-026-35, UPC 681131395298", "product_quantity": "315,842 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240130", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #: A2E01, Exp. Date Apr-24; A2L05, Exp. Date Nov-24, A3B01, Exp. Date Jan-25;  A3C01, Exp. Date Feb-25", "more_code_info": ""}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "75565", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0170-2017", "product_description": "Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-206-06 and 59310-206-08 (Physician Samples).", "product_quantity": "201, 234 Canisters", "reason_for_recall": "Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.", "recall_initiation_date": "20161101", "center_classification_date": "20161208", "termination_date": "20180206", "report_date": "20161214", "code_info": "Lot #: 150096, Exp. 3/2017; Lot #: 150327, Exp. 10/2017"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0344-2016", "product_description": "Riboflavin-5-Phosphate Injectable,10mg/mL, 10mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "25 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:C0404989          C0398689  C0403441", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LORAZEPAM 2MG/ML INJECTABLE\t10 ML  \t  \t  \t  \t  \t20 ML  \t200 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1566-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA212918"], "brand_name": ["ATOVAQUONE"], "generic_name": ["ATOVAQUONE"], "manufacturer_name": ["Bionpharma Inc."], "product_ndc": ["69452-252"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOVAQUONE"], "rxcui": ["308429"], "spl_id": ["0d5fc0ab-9cfa-0a79-e063-6394a90a2b61"], "spl_set_id": ["bff4f4fc-6307-f414-e053-2a95a90ac0de"], "package_ndc": ["69452-252-87"], "is_original_packager": [true], "upc": ["0369452252871"], "nui": ["N0000175482", "N0000175485"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "unii": ["Y883P1Z2LT"]}, "product_type": "Drugs", "event_id": "95345", "recalling_firm": "Bionpharma Inc.", "address_1": "400 Alexander Park Ste 2-4b", "address_2": "", "postal_code": "08540-6539", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the U.S.A.", "recall_number": "D-0012-2025", "product_description": "Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.", "product_quantity": "1,980 bottles", "reason_for_recall": "Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.", "recall_initiation_date": "20240917", "center_classification_date": "20241015", "termination_date": "20250916", "report_date": "20241023", "code_info": "Lot # 2310083, Exp. 09/30/2025", "more_code_info": ""}, {"country": "United States", "city": "Somerset", "address_1": "400 Campus Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified -  A private label distributor noted unfiled NDC numbers on EQ ClearLax Polyethylene Glycol 3350 NF Powder Solution of various sizes.", "address_2": "", "product_quantity": "2,229,052 bottles", "code_info": "a) M16425A, Exp 06/18; M16463A, Exp 7/18; M16516A, Exp 8/19; M16605A, Exp 10/19; M17005A, Exp 1/20; S700119, S700157, Exp 3/20; S700228, Exp  4/20; S700304, Exp 5/20; S700510, Exp 7/20; S700780, Exp 10/20; S701063,  S701112, Exp 12/20; S800170, Exp 2/21; S800349, Exp 3/21; S800366, Exp 4/21; S800453, Exp 5/21; b) M16560A, M16561A, M16562A, Exp 9/19; M16607A, Exp 11/19; S700202, Exp 4/20; S700415, Exp 6/20; S700511, Exp 7/20; S700752, Exp 9/20; S700902, Exp 10/20; S701119, Exp 12/20; S800097, Exp 2/21; S800296, S800306, Exp 3/21.", "center_classification_date": "20180703", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Equate ClearLAX, Polyethylene Glycol 3350 Powder for Solution, OS Osmotic Laxative, OTC, packaged in a) 119 g bottle (NDC 49035-312-07), b) 238 g bottle (NDC 49035-312-08), Distributed by: Wal-mart Stores, Inc., Bentonville, AR 72716", "report_date": "20180711", "classification": "Class III", "openfda": {}, "recalling_firm": "LUPIN SOMERSET", "recall_number": "D-0907-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80266", "termination_date": "20210202", "more_code_info": "", "recall_initiation_date": "20180613", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Columbia", "address_1": "3801 Mojave Ct Ste 101", "reason_for_recall": "Stability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.", "address_2": "", "product_quantity": "96 bags", "code_info": "Lot#: AC-015569, Exp. 03/26/2018", "center_classification_date": "20180329", "distribution_pattern": "Medical Facility in MO", "state": "MO", "product_description": "Vancomycin 1.25g added to 250 mL of 0.9% Sodium Chloride IV bag, Rx only, APOLLOcare, 3801 Mojave Ct., Suite 101, Columbia, MO 65202, NDC 71170-254-25.", "report_date": "20180404", "classification": "Class II", "openfda": {}, "recalling_firm": "Apollo Care", "recall_number": "D-0615-2018", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "79517", "termination_date": "20180531", "more_code_info": "", "recall_initiation_date": "20180307", "postal_code": "65202-4042", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA060304"], "brand_name": ["NEOMYCIN SULFATE"], "generic_name": ["NEOMYCIN SULFATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-1177"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NEOMYCIN SULFATE"], "rxcui": ["866042"], "spl_id": ["18e9e5b7-e08c-445e-86bb-90bc0953eda9"], "spl_set_id": ["777dbfab-f83e-4738-ae1e-78619a9f82a7"], "package_ndc": ["0093-1177-01"], "is_original_packager": [true], "upc": ["0300931177018"], "unii": ["057Y626693"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0574-2021", "product_description": "NEOMYCIN SULF TABLETS, USP, 500mg, 100-count bottle, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC: 0093-1177-01", "product_quantity": "41 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3006910"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077750"], "brand_name": ["CABERGOLINE"], "generic_name": ["CABERGOLINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5420"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CABERGOLINE"], "rxcui": ["199703"], "spl_id": ["ee38a597-4dd9-4b40-b168-97e919ead1c7"], "spl_set_id": ["74b61e8a-7ae9-4996-85ec-df23c56de16f"], "package_ndc": ["0093-5420-88"], "is_original_packager": [true], "nui": ["M0007652", "N0000175827"], "pharm_class_cs": ["Ergolines [CS]"], "pharm_class_epc": ["Ergot Derivative [EPC]"], "unii": ["LL60K9J05T"]}, "product_type": "Drugs", "event_id": "61725", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-128-2013", "product_description": "CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88", "product_quantity": "13,232 bottles", "reason_for_recall": "Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life", "recall_initiation_date": "20120424", "center_classification_date": "20130116", "termination_date": "20131218", "report_date": "20130123", "code_info": "Lot number 6A007046V, exp 07/12"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-595-2015", "product_description": "Clomipramine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "87144 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0597-2017", "product_description": "SULFACETAMIDE 10%/HYDROCORTISONE 1% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73899", "recalling_firm": "Baptist Health Medical Towers Pharmacy and Infusion Services", "address_1": "9601 Baptist Health Dr Ste 109", "address_2": "N/A", "postal_code": "72205-6323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Arkansas", "recall_number": "D-0931-2016", "product_description": "Nafcillin 3 grams in 277 mL 0.9% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR", "product_quantity": "7 bags", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20160418", "center_classification_date": "20160529", "termination_date": "20161223", "report_date": "20160608", "code_info": "All product remaining within expiry"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1384-2019", "product_description": "Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution, 5 mg/1.5 mg per 5 mL, Rx Only, 16 FL. oz. (473 mL)  bottle, NDC:13668-577-10  Distributed by Torrent Pharma Inc., Basking Ridge, NJ 07920.", "product_quantity": "7,728 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 18E034, Exp. 05/2020; 19A015, Exp. 01/2021."}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84122", "recalling_firm": "Sanofi-Aventis U.S. LLC", "address_1": "55 Corporate Dr", "address_2": "", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0544-2020", "product_description": "Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219.     NDC's  66715-9736-2  66715-9736-3  66715-9736-8", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191022", "center_classification_date": "20191201", "report_date": "20191211", "code_info": "all lots", "more_code_info": ""}, {"status": "Terminated", "city": "Maumee", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87633", "recalling_firm": "Spartan Chemical Co Inc", "address_1": "1110 Spartan Dr", "address_2": "N/A", "postal_code": "43537-1725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico; Mexico", "recall_number": "D-0360-2021", "product_description": "foamyiQ Lemon Blossom Hand Sanitizer (benzalkonium chloride 0.1%), Net Contents: 42.27 oz/1250 ml per foam pump cartridge, For Institutional and Industrial Use Only, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA. UPC 7 53727 26454 4 NDC: 64009-202-06", "product_quantity": "26,328 cartridges", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210329", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210421", "code_info": "Lot, expiry: Lot 526756, exp 9/22/2022; Lot 527499, exp 9/28/2022; Lot 527501, exp 9/30/2022"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87051", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0221-2021", "product_description": "Levetiracetam Oral Solution, 100 mg/mL, 16 fl oz (473 mL) bottle, Rx Only, HI-TECH PHARMACAL CO., INC., Amityville, NY 11701; NDC 50383-241-16", "product_quantity": "22,248 bottles", "reason_for_recall": "Defective container: Customer complaints for oral solution leaking from bottles.", "recall_initiation_date": "20201228", "center_classification_date": "20210111", "termination_date": "20220809", "report_date": "20210120", "code_info": "Lot #: 373859, 373863, and 373865, Exp 05/2022; 374586, Exp 06/2022"}, {"country": "United States", "city": "Chino Hills", "address_1": "4195 Chino Hills Pkwy", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared tadalafil. The presence of tadalafil makes Rhino Extreme 50000 an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.", "address_2": "#609", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180518", "distribution_pattern": "Nationwide within the US", "state": "CA", "product_description": "Rhino 69 Extreme 50000 packaged in 1 capsule per blister pack, Distributed by AMA Wholesale Inc. Chino Hills, CA,  91709-2618, UPC Code: 718122071128", "report_date": "20180530", "classification": "Class I", "openfda": {}, "recalling_firm": "AMA Wholesale", "recall_number": "D-0821-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "79852", "termination_date": "20210407", "recall_initiation_date": "20180412", "postal_code": "91709-2618", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Upper Darby", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94355", "recalling_firm": "Dercher Enterprises, Inc., DBA Gordon Laboratories", "address_1": "6801 Ludlow St", "address_2": "N/A", "postal_code": "19082-2408", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0495-2024", "product_description": "Gordofilm Wart Remover (salicylic acid 16.7% USP) packaged in 15 cc glass jars, Gordon Laboratories, Upper Darby PA 19082, NDC 10481-3009-01", "product_quantity": "5,247 glass jars", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20240412", "center_classification_date": "20240513", "report_date": "20240522", "code_info": "Lot #: F135, Exp. Date March 2025; F146, Exp. Date April , 2025; G103, Exp. Date January 2026; G194, Exp. Date September 2026"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "169 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015:    02272015@1, 8/26/2015; 12182015@67, 6/16/2015; 02062015@141, 8/5/2015; 04222015@13, 9/29/2015; 04072015@33, 10/4/2015; 04212015@13, 10/18/2015; 04082015@7, 10/5/2015 ; 04142015@24, 10/11/2015; 04272015@84, 10/24/2015; and 05082015@7, 11/4/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Nandrolone Decanoate 200 mg/ml Injection, ml Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1616-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "76678", "recalling_firm": "Complete Pharmacy and Medical Solutions LLC", "address_1": "5829 Nw 158th St", "address_2": "N/A", "postal_code": "33014-6721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed throughout Florida", "recall_number": "D-0917-2017", "product_description": "Human Chorionic Gonadotropin, 125 IU HCG, in 0.5 ml syringe, subcutaneous administration, Rx only,  Complete Pharmacy & Medical Solutions, Miami Lakes, FL 33014", "product_quantity": "1890 syringes", "reason_for_recall": "Non-sterility: presence of mold confirmed by outside laboratory at the 14 day culture.", "recall_initiation_date": "20151229", "center_classification_date": "20170613", "report_date": "20170621", "code_info": "Lot # 2079ps5, Exp 02/01/2016"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "900 bags", "code_info": "Lot #: 138-20181105@65,138-20181105@64, 138-20181105@63, BUD 8/19/2018.", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "HEPARIN 12,500 Units in 5% Dextrose. (Heparin Sodium, USP 12,500 Units, 5% Dextrose Inj., USP 250 mL) Volume: 252.5 mL. Single dose bag. Avella Specialty Pharmacy, 24416 N 19th Avenue Phoenix, AZ 85085. NDC 42852-745-25", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0947-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0244-2025", "product_description": "Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-761-01.", "product_quantity": "58,368 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233270, 19233278, 19233285, Exp.: 7/2025; 19233806, Exp.: 8/2025; 19240954, Exp.: 2/2026; 19241854, Exp.: 4/2026."}, {"status": "Ongoing", "city": "Newton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96052", "recalling_firm": "First Aid Beauty Ltd", "address_1": "70 Bridge St", "address_2": "Suite 203", "postal_code": "02458-1140", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0206-2025", "product_description": "First Aid Beauty Ultra Repair Cream, colloidal oatmeal 0.5%, Coconut Vanilla, Net Wt. 396.8 g (14 OZ), DISTR. BY: First Aid Beauty LTD, Newton, MA, 02458, UPC 8 15517 02955 6", "product_quantity": "2756 jars", "reason_for_recall": "CGMP Deviations; product intended for quarantine was inadvertently distributed", "recall_initiation_date": "20241223", "center_classification_date": "20250121", "report_date": "20250129", "code_info": "Lots 24D44, Exp 4/10/2026 & 24D45, 4/11/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0994-2017", "product_description": "Potassium PHOSphate in 0.9% Sodium Chloride Injection, 9 mMol in 100 mL in 150 mL Intravia Bag, Rx Only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5286 NDC# 61553-286-48", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lot: 171520062D, 8/31/2017"}, {"status": "Terminated", "city": "Moon Township", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["SENSODYNE COMPLETE PROTECTION"], "generic_name": ["STANNOUS FLUORIDE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0135-0572", "0135-0573"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["STANNOUS FLUORIDE"], "rxcui": ["416784"], "spl_id": ["78b76a64-361a-41e8-aead-29ac143c0901"], "spl_set_id": ["e3cc3146-8aed-4f6b-a252-e379418c2b8d"], "package_ndc": ["0135-0573-02", "0135-0573-03", "0135-0572-02", "0135-0572-03"], "is_original_packager": [true], "unii": ["3FTR44B32Q"]}, "product_type": "Drugs", "event_id": "71750", "recalling_firm": "GlaxoSmithkline Consmer Healthcare", "address_1": "1000 GSK Drive", "address_2": "N/A", "postal_code": "15108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico & Taiwan", "recall_number": "D-1321-2015", "product_description": "SENSODYNE EXTRA FRESH COMPLETE PROTECTION, 3.4 oz.(96.4 g) tubes, Manufactured by Oratech, South Jordan UTAH 84095, Distributed by GlaxoSmithKline, Consumer Healthcare, L.P., Moon Township, PA 15108, NDC 0135-0572-02", "product_quantity": "50,860 tubes", "reason_for_recall": "Presence of Foreign Substance: Fragments of wood found when the product was extruded onto a toothbrush.", "recall_initiation_date": "20150715", "center_classification_date": "20150811", "termination_date": "20170419", "report_date": "20150819", "code_info": "Lot #    C4D061, Exp 03/16  C4E161, C4E211, Exp 04/16  C4F051, Exp 05/16  C4H111, Exp 07/16"}, {"status": "Ongoing", "city": "Exton", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95190", "recalling_firm": "ProRx LLC", "address_1": "619 Jeffers Cir", "address_2": "", "postal_code": "19341-2540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0650-2024", "product_description": "Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial,  ProRx, 267-565-7008, NDC 84139-225-01", "product_quantity": "2,490 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240822", "center_classification_date": "20240905", "report_date": "20240911", "code_info": "Lot #: ProRx031924, BUD 09/18/2024 ProRx032624, BUD 09/25/2024 ProRx041324, BUD 10/12/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84213", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia", "recall_number": "D-0497-2020", "product_description": "Kali Phosphoricum 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV  25411, barcode 7 40640 64195 8.", "product_quantity": "417 bottles", "reason_for_recall": "CGMP Deviations: products were not manufactured under current good manufacturing practices.", "recall_initiation_date": "20191108", "center_classification_date": "20191118", "termination_date": "20230104", "report_date": "20191127", "code_info": "Lot #: BR18B272"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0116-2016", "product_description": "PROGESTERONE, Pellet, 100 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "21 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12292014@29, t11262014@15, t11202014@25, t11202014@10, t08292014@26, t07072015@20, t06222015@10, t06162015@16, t06012015@10, t05292014@20, t04302015@13, t04162015@8, t03102015@3, t02062015@13, t01062015@20."}, {"country": "United States", "city": "Nashville", "address_1": "245B Great Circle Road", "reason_for_recall": "CGMP Deviation: Discoloration; Product fails specification for appearance/color.  A complaint was received regarding an abnormal appearance of children's ibuprofen suspension.", "address_2": "", "product_quantity": "3764 cups", "code_info": "600709, Use by:  04/14; 598148, Use by 04/14; 567904, Use by 01/14; 606466, Use by 05/14", "center_classification_date": "20140204", "distribution_pattern": "GA, KY, TN", "state": "TN", "product_description": "CHILDREN'S IBUPROFEN, ORAL SUSPENSION, 200 mg/10mL cup BERRY FLAVOR, ALCOHOL FREE, MFG: ACTAVIS, PGK BY SAFECOR Columbus, OH", "report_date": "20140212", "classification": "Class II", "openfda": {}, "recalling_firm": "Central Shared Services dba Parallon", "recall_number": "D-1062-2014", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "66313", "termination_date": "20140204", "more_code_info": "", "recall_initiation_date": "20130823", "postal_code": "37228", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021395"], "brand_name": ["SPIRIVA"], "generic_name": ["TIOTROPIUM BROMIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0075"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL", "RESPIRATORY (INHALATION)"], "substance_name": ["TIOTROPIUM BROMIDE MONOHYDRATE"], "rxcui": ["485032", "580261"], "spl_id": ["902426f3-c843-416d-a1e3-b64eafc1f32d"], "spl_set_id": ["820839ef-e53d-47e8-a3b9-d911ff92e6a9"], "package_ndc": ["0597-0075-41", "0597-0075-75", "0597-0075-47"], "is_original_packager": [true], "unii": ["L64SXO195N"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0453-2021", "product_description": "Spiriva HandiHaler (tiotropium bromide inhalation powder) For Oral Inhalation Only 18 mcg (as tiotropium) per capsule Rx only NDC 0597-0075-41 Manufactured by: Boehringer Ingelheim (BI) Pharma GmbH & Co. KG Ingelheim, Germany  Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA and Pfizer, Inc. New York, NY 10017 USA", "product_quantity": "2611 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "5098"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1434-2020", "product_description": "Progesterone Modified Release 200 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "900 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "02-05-2020:30@19, BUD 8/3/2020"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1804-2019", "product_description": "PERJETA 420 MG/250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1015-2017", "product_description": "fentaNYL 2 mcg/mL + BUPIvacaine 0.125% PF in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 ---  NDC# 70004-0254-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170503@75 BUD: 8/1/2017; 20170511@21 BUD: 8/9/2017"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85070", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1003-2020", "product_description": "Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC carton: 60687-322-01; NDC Unit Dose Card: 60687-322-11", "product_quantity": "53,619 cartons", "reason_for_recall": "CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.", "recall_initiation_date": "20191120", "center_classification_date": "20200312", "termination_date": "20220804", "report_date": "20200318", "code_info": "Lot, expiry:  Lots  179516, 179745, exp 12/31/2019; Lot 180712, exp 02/29/2020; Lot 180819, exp 04/30/2020; Lots 181403, 182544, 183155, 183236, exp 05/31/2020; Lots 185739, 186600, 186702, exp 12/31/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Mundelein", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "72323", "recalling_firm": "Medline Industries Inc", "address_1": "1 Medline Pl", "address_2": "", "postal_code": "60060-4485", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0662-2016", "product_description": "ACETAMINOPHEN EXTRA-STRENGTH PAIN RELIEVER tablets, 500 mg, 100-count bottle, Distributed by Medline Industries, Inc., Mundelein, ILL 60060, NDC 53329-641-30.", "product_quantity": "7,372 HDPE Bottles", "reason_for_recall": "Labeling: Label Error on Declared Strength- Bottles containing 500 mg acetaminophen tablets mislabeled to contain 325 mg tablets.", "recall_initiation_date": "20150925", "center_classification_date": "20160212", "termination_date": "20160629", "report_date": "20160224", "code_info": "lot # 45810; Exp. 05/18", "more_code_info": ""}, {"status": "Terminated", "city": "Clifton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68891", "recalling_firm": "SST Corporation", "address_1": "635 Brighton Rd", "address_2": "N/A", "postal_code": "07012-1027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "CA", "recall_number": "D-1517-2014", "product_description": "Tetrahydrozoline HCL, 16 kg drum.  Societa Italiana Medicinali Scandicci (S.I.M.S.), Made in Italy. NDC 12660-0048 CAS #522-48-5", "product_quantity": "1 Drum", "reason_for_recall": "CGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy.", "recall_initiation_date": "20140717", "center_classification_date": "20140806", "termination_date": "20160804", "report_date": "20140813", "code_info": "Lot: 168.862, Expiry: 6/2017"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0108-2022", "product_description": "BLUE TREE LIPO EXTREME (/W METHYLCOBALAMIN) INJECTION  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "8 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 09172021:87 BUD: 12/16/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74702", "recalling_firm": "Actavis Inc", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1457-2016", "product_description": "Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH  45237, NDC 00591-0900-30", "product_quantity": "167,152 bottles", "reason_for_recall": "Failed Dissolution Specifications: Glipizide 2.5 mg ER  Tablets exceeded  dissolution specification rates for the 10 hour testing point.", "recall_initiation_date": "20160630", "center_classification_date": "20160815", "termination_date": "20170703", "report_date": "20160824", "code_info": "Lot # 3132593, 3132594, 3134420, 3134421,3134422, Exp. 02/17"}, {"status": "Terminated", "city": "Pearl River", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91576", "recalling_firm": "Urban Electric Power", "address_1": "401 N Middletown Rd Bldg 155", "address_2": "", "postal_code": "10965-1298", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0264-2023", "product_description": "Ohm Sanitizer Spray (alcohol (ethyl alcohol) 80% v/v, 8 FL OZ (237 ML) bottles.", "product_quantity": "609 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.", "recall_initiation_date": "20230117", "center_classification_date": "20230208", "termination_date": "20240226", "report_date": "20230215", "code_info": "All lots within expiry", "more_code_info": ""}]